We previously reported that loss of Bmal1 (Bmal1KO) in the B16-F10 murine melanoma cell line diminished tumor growth in immunocompetent C57BL/6 mice and altered time-of-day specificity of response to anti-cancer drugs18. This evidence concerns the gene BMAL1 and cancer.